Experiment on Immune Protection of DNA Vaccine Against Porcine Circovirus 2 in Mice
张宁,侯韶毅,韦英益,李茂宁,肖爱欢,谢丽华,刘芳,高永锐,卢桂娟,陆有飞,黄伟坚
2010-01-01
Abstract:To study immune efficacy of DNA vaccines with truncated ORF2 gene of porcine circovirus 2(PCV-2), the ORF2 associated gene fragments, including A (complete ORF2), B (51-100aa), C (101-150aa), D (181-235aa), E (151-200aa), F (51-150aa), G (101-235aa) and H (51-235aa), were amplified from PCV-2 GXWZ-1 strain by PCR and cloned into pcDNA3.0 vector to construct the eukaryotic expression plasmids pcDNA-A, pcDNA-B, pcDNA-C, pcDNA-D, pcDNA-E, pcDNA-F, pcDNA-G and pcDNA-H. The eight purified recombinant plasmids were transfected into PK-15 cells and their expressed products were examined by indirect immunofluorescence assay. Experimental mice were randomly divided into 9 groups, including 7 immunity groups, positive and negative control groups. The mice in the immunity groups were m.i. vaccinated with the purified expressed plasmid. After twice vaccination, the immunity groups and positive control were p.i. injected with the suspension of PCV-2 GXWZ-2 strain, and negative control with physiological saline. Weight record and pathological observation and PCR amplification were performed. The results demonstrated that fluorescence could be observed in the cells transfected with pcDNA-B, pcDNA-C, pcDNA-D, pcDNA-E, pcDNA-F and pcDNA-G. In the three weeks after challenge, some mice in the immunity groups were positive in the first or second week, and all were negative in the third week. Pathological observation revealed that the lesions in the immunity groups were less than those in the positive control. Body weight growth rate in the positive control was lower than the two other groups. It suggested that the DNA vaccines provided the distinct protection against PCV-2 in the vaccinated mice.